Did FDA Apply Rigorous Standards in Approving Paxlovid?
(MedPage Today) — On May 25, the FDA approved nirmatrelvir-ritonavir (Paxlovid) for treating adult outpatients with mild to moderate COVID-19 who are at risk for severe disease. Until then, nirmatrelvir-ritonavir had only received emergency use…
Powered by WPeMatico
